Brief: Zevra Therapeutics Appoints Neil F. Mcfarlane As President, Chief Executive Officer And Director
Oct 10 (Reuters) - Zevra Therapeutics Inc ZVRA.O :
* ZEVRA THERAPEUTICS APPOINTS NEIL F. MCFARLANE AS
PRESIDENT,
CHIEF EXECUTIVE OFFICER AND DIRECTOR
* ZEVRA THERAPEUTICS INC - CHRISTAL MICKLE TRANSITIONS BACK
TO
CHIEF DEVELOPMENT OFFICER
* ZEVRA THERAPEUTICS INC - NEIL F. MCFARLANE NAMED
PRESIDENT, CEO
OF ZEVRA AND APPOINTED TO BOARD OF DIRECTORS, EFFECTIVE OCTOBER
10, 2023
Source text for Eikon: ID:nGNX42Fgkn
Further company coverage: ZVRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor